Netherlands: InnoSer expands preclinical neurology portfolio with Sylics acquisition

InnoSer, a contract research organization (CRO) supporting preclinical drug development from its facilities in Belgium and the Netherlands, is to acquire Sylics, a CRO specializing in efficacy testing using rodent in vivo models of neurological and psychiatric diseases. The acquisition serves to expand InnoSer’s preclinical neurology portfolio. Through the acquisition, InnoSer International will expand its…

You must be a HMI Subscriber to view this content.

Subscribe Now »